Supported by the National Cancer Institute (NCI), the CTO is one of 12 centers across the U.S. as part of a collaborative network which is exploring new and innovative approaches to improve understanding and control of cancer. The network and centers bring together scientific teams and individual scientists from the fields of physics, mathematics, chemistry, and engineering to examine cancer using approaches that have not been followed in cancer research to date.
The NCI's goal is to join these often disparate areas of science through its various support mechanisms, including centers of excellence, to better understand the physical and chemical forces that shape and govern the emergence and behavior of cancer at all levels. The NCI anticipates that this initiative will foster the development of innovative ideas and new fields of study based on knowledge of the biological and physical laws and principles that define both normal and tumor systems. This is a new and exciting frontier for cancer research.
Arizona State University, Tempe, AZ
Cornell University, Ithaca, NY
H. Lee Moffitt Cancer Center & Research Institute,
Johns Hopkins University, Baltimore, MD
Massachusetts Institute of Technology, Cambridge, MA
Memorial Sloan-Kettering Cancer Center, New York, NY
Northwestern University, Chicago, IL
Princeton University, Princeton, NJ
The Scripps Research Institute, La Jolla, CA
University of California-Berkeley, Berkeley, CA
University of Southern California, Los Angeles, CA
The Methodist Hospital Research Institute, Houston, TX